Brown Rudnick has added more depth to its global life sciences bench with the arrival of Neil Di Spirito as a partner in Washington, D.C.

Di Spirito has spent the last three years at Epstein Becker & Green in D.C., and was previously at Ballard Spahr, where he established the firm’s Food and Drug Administration practice. At Brown Rudnick, he will continue his focus on regulatory and compliance services for pharmaceutical, biologics, and medical device clients, especially in FDA interactions and compliance.